Brief: Galera Therapeutics Reports Q3 Loss Per Share $0.69
Nov 10 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* Q3 LOSS PER SHARE $0.69
* Q3 EARNINGS PER SHARE ESTIMATE $-0.77 -- REFINITIV IBES
DATA
* GALERA THERAPEUTICS - EXPECTS EXISTING CASH RESOURCES WITH
EXPECTED PAYMENTS WILL FUND OPERATING EXPENSES AND CAPITAL
EXPENDITURE INTO H2 OF 2022
Source text for Eikon: ID:nGNX2rKNDp
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement